- Home
- SION vs DEA Comparison
SION vs DEA Comparison
Compare SION & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SION
- DEA
- Stock Information
- Founded
- SION 2019
- DEA 2011
- Country
- SION United States
- DEA United States
- Employees
- SION N/A
- DEA N/A
- Industry
- SION
- DEA Real Estate Investment Trusts
- Sector
- SION
- DEA Real Estate
- Exchange
- SION NYSE
- DEA Nasdaq
- Market Cap
- SION 920.2M
- DEA 912.0M
- IPO Year
- SION 2025
- DEA 2015
- Fundamental
- Price
- SION $20.47
- DEA $23.19
- Analyst Decision
- SION Strong Buy
- DEA Hold
- Analyst Count
- SION 1
- DEA 4
- Target Price
- SION $32.00
- DEA $27.69
- AVG Volume (30 Days)
- SION 260.6K
- DEA 519.5K
- Earning Date
- SION 08-25-2025
- DEA 07-30-2025
- Dividend Yield
- SION N/A
- DEA 7.75%
- EPS Growth
- SION N/A
- DEA N/A
- EPS
- SION N/A
- DEA 0.41
- Revenue
- SION N/A
- DEA $314,385,000.00
- Revenue This Year
- SION N/A
- DEA $7.80
- Revenue Next Year
- SION N/A
- DEA $8.54
- P/E Ratio
- SION N/A
- DEA $56.87
- Revenue Growth
- SION N/A
- DEA 6.82
- 52 Week Low
- SION $7.26
- DEA $19.33
- 52 Week High
- SION $25.19
- DEA $36.31
- Technical
- Relative Strength Index (RSI)
- SION N/A
- DEA 59.41
- Support Level
- SION N/A
- DEA $22.23
- Resistance Level
- SION N/A
- DEA $23.35
- Average True Range (ATR)
- SION 0.00
- DEA 0.51
- MACD
- SION 0.00
- DEA 0.03
- Stochastic Oscillator
- SION 0.00
- DEA 82.71
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.